Coagulation Profile of Recipients with Tendency to Hyper coagulate for Adult Living Liver Transplantation by use of both Routine Lab and Thromboelasto

Study of Coagulation Profile of Recipients with Tendency to Hyper coagulate for Adult Living Liver Transplantation by use of both Routine Lab and Thromboelastometry

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201405000814129

Enrollment

Registered

2014-04-21

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Surgery Patients undergoing liver transplantation

Interventions

Non Hypercoagulable

Hypercoagulable

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Preoperative measurement of the following laboratory tests: protein C, protein S, antithrombin III , factor V leidin Mutation, lupus anticoagulant, homocystein IgG IgM and antiphospholipid

Exclusion criteria

Exclusion criteria: Any factor that interfere with coagulation such as patient on heparin, oral anticoagulant, or taking plasma , on procoagulant as activated factor seven (novoseven).

Design outcomes

Primary

Measure	Time frame
prothrombin time (PT) and international normalized ratio (INR) , Partial thromboplastin time (PTT) , Thromboelastogram (INTEM, EXTEM, FIBTEM),platelet,fibrinogen	—

Secondary

Measure	Time frame
Preoperative measurement of the following laboratory tests: protein C, protein S, antithrombin III , factor V leidin Mutation, lupus anticoagulant, homocystein IgG IgM and antiphospholipid.	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient information Manager

elsayedamr@yahoo.com002-01223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026